311
|
|
|
Epsin 1 |
- |
|
312
|
|
|
Epsin 2 |
EHB21 |
|
313
|
|
|
Epsin 3 |
- |
|
314
|
|
|
Erythropoietin |
DBAL, ECYT5, EP, MVCD2 |
Alzheimer disease, Anemia, Hemolytic anemia, Secondary polycythemia, Beta thalassemia, Brain injuries, Calcinosis, Cardiomyopathy, Central nervous system disease, Ischemic heart disease, Cognition disorder, Congestive heart failure, Coronary artery disease, Crohn disease, Degenerative disorder, Delirium, dementia, and cognitive disorders, Diabetic angiopathies, Diabetic neuropathy, Diabetic peripheral angiopathy, Diabetic retinopathy, Diamond-blackfan anemia, Disorders of porphyrin metabolism, Erythrocytosis, Gastric ulcer, Glaucoma, Heart disease, Heart failure, Congenital heart septal defect, Hemolytic uremic syndrome, Hypertension, Inflammatory bowel disease, Kidney disease, Kidney failure, Melanoma, Microvascular complications of diabetes mellitus, Myelodysplastic syndrome, Myocardial infarction, Myocardial ischemia, Nephrotic syndrome, Neurodegenerative disorder, Pancytopenia, Paraneoplastic syndrome, Parkinson disease, Polycythemia, Polyneuropathy, Sarcoma, Schizophrenia, Status epilepticus, Thrombocytopenia, Thrombosis, Thyroid neoplasms, Transient ischemic attack, Diabetes mellitus type 2, Ulcerative colitis, Uremia, Vascular disease, Venous thrombosis, Ventricular fibrillation, Ventricular septal defectView all (44 more) |
315
|
|
|
Elongin BC and polycomb repressive complex 2 associated protein |
C17orf96, PRR28 |
|
316
|
|
|
Erythropoietin receptor |
EPO-R |
|
317
|
|
|
Epiplakin 1 |
EPIPL, EPIPL1 |
|
318
|
|
|
Glutamyl-prolyl-tRNA synthetase 1 |
EARS, EPRS, GLUPRORS, HLD15, PARS, PIG32, QARS, QPRS |
|
319
|
|
|
Epidermal growth factor receptor pathway substrate 15 |
AF-1P, AF1P, MLLT5 |
|
320
|
|
|
Epidermal growth factor receptor pathway substrate 15 like 1 |
EPS15R |
|
